Skip to the page

Data / Form D filings / Galenus Precision Pharmacy, Inc.

Galenus Precision Pharmacy, Inc.: Form D filings

Galenus Precision Pharmacy, Inc., a pharmaceuticals company in Mt. Laurel, NJ, filed 2 Form D notices with the SEC in 2026. The latest, on February 18, 2026, reports $5.4 million sold of a $6.6 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
350 FELLOWSHIP ROAD, SUITE 101, Mt. Laurel, NJ, 08054
Phone
(844) 425-3687
Industry
Pharmaceuticals
Entity type
Limited Partnership
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2107049

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 18, 2026New notice$6,599,999$5,399,999$1,200,0003Feb 6, 2026sec.gov
Feb 18, 2026New notice$2,817,250$1,940,500$876,75020Aug 11, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Calvin H. KnowltonDirector, Executive Officer
Orsula V. KnowltonDirector, Executive Officer
Jarred BressnerDirector
Saul RichterDirector
Dennis HellingDirector
Samira BeckwithDirector
Gordon TunstallDirector

Other pharmaceuticals companies in New Jersey that filed recently

Every Form D from the week of Feb 16, 2026 · All recent filings in New Jersey · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Galenus Precision Pharmacy, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.